Reply: Seeking an Appropriate Primary Endpoint for Trials Comparing DCB and DES

Free article

Comment

Bernardo Cortese et al. JACC Cardiovasc Interv. 2021.

Free article

. 2021 Mar 22;14(6):710-711.

doi: 10.1016/j.jcin.2021.01.037.

No abstract available

Comment on

Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial.
Cortese B, Di Palma G, Guimaraes MG, Piraino D, Orrego PS, Buccheri D, Rivero F, Perotto A, Zambelli G, Alfonso F. Cortese B, et al. JACC Cardiovasc Interv. 2020 Dec 28;13(24):2840-2849. doi: 10.1016/j.jcin.2020.08.035. Epub 2020 Nov 25. JACC Cardiovasc Interv. 2020. PMID: 33248978 Clinical Trial.
An Inappropriate Primary Endpoint.
Ormiston J, Webster M. Ormiston J, et al. JACC Cardiovasc Interv. 2021 Mar 22;14(6):709-710. doi: 10.1016/j.jcin.2021.02.004. JACC Cardiovasc Interv. 2021. PMID: 33736778 No abstract available.
Choice of Primary Endpoint for Trials Comparing Balloon Angioplasty and Stenting.
Byrne RA, Colleran R. Byrne RA, et al. JACC Cardiovasc Interv. 2021 Mar 22;14(6):709. doi: 10.1016/j.jcin.2021.01.020. JACC Cardiovasc Interv. 2021. PMID: 33736779 No abstract available.